Dr Reddy's Laboratories is set to acquire Haleon Plc's NRT business, including Nicotinell, for GBP 500 million. The deal encompasses various NRT formats and potential contingent payments. This acquisition marks a significant step for Dr Reddy's in strengthening its position in the global consumer healthcare market outside the US.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/mX7S08H
https://ift.tt/0twPsC2
